Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISPEN: Transcricoid vs Spray Lignocaine in EBUS-TBNA
NCT02981264Completed
- Sponsor
- AIIMS New Delhi
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in pulmonary disease (2 arms), sponsored by AIIMS New Delhi. Primary endpoints: Overall cough count at 12 months and Operator rated overall procedure satisfaction at 1 year. Started Jan 2017; status: completed.
02
Drugs
lidocaine
03
Conditions
pulmonary disease
Beyond the preview
Go deeper on NCT02981264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981264.